ACTRN12619001743156招募中未知
FIT for Purpose: personalised surveillance colonoscopy for people at increased risk of colorectal and the effect on resource cost to the healthcare system.
Flinders University of South Australia0 个研究点目标入组 4,500 人开始时间: 2019年12月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 4,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Inclusion Groups 1 & 2:
- •Males and females enrolled in the SCOOP clinical CRC surveillance program.
- •Aged older than 18 years.
- •Individuals who have either had a previous colonoscopy finding of adenoma or those with a significant family history of colorectal cancer (CRC).
- •Individuals with a colonoscopy surveillance interval of at least three years.
- •Further inclusion for Group 1 only: (to be randomised into control or intervention arms)
- •Those due for surveillance colonoscopy 2019 to 2023.
- •Individuals with a zero FIT result within the last 3 years.
- •Further inclusion for Group 2 only: (for a single survey)
- •Individuals not scheduled for a surveillance colonoscopy during the study period.
排除标准
- •Individuals under 18 years of age.
- •Individuals with a familial syndrome or inflammatory bowel disease (IBD).
- •Individuals who have had bowel cancer surgery with resection.
- •Individuals with the indication for colonoscopy being a positive interval FIT.
- •Individuals with a colonoscopy surveillance interval less than three years.
研究者
相似试验
已完成
不适用
It's LiFe! Innovative monitoring and personalised feedback as a self-management tool in disease management programmes for people with COPD and/or type 2 diabetes; a randomised controlled trial1001265310037454Chronic Obstructive Pulmonary Disease (longziekte)type 2 Diabetes (suikerziekte)NL-OMON39684niversiteit Maastricht240
尚未招募
不适用
Establishment of surveillance system for individuals diagnosed with COVID-19.CTRI/2020/08/027078Tata Memorial Hospital
已完成
4 期
An active surveillance to monitor the real world safety of Nintedanib in Indian Idiopathic Pulmonary Fibrosis (a type of lung disease in which tissue deep in our lungs becomes thick and stiff, or scarred, over the time) patientsCTRI/2017/02/007867Boehringer Ingelheim India Pvt Ltd21
已完成
4 期
An active surveillance to monitor the real world safety of Nintedanib in Indian NSCLC patientsCTRI/2017/02/007857Boehringer Ingelheim India Pvt Ltd28
尚未招募
不适用
Personalized Care enabled by activity monitoringdementie en kwetsbare ouderen, allen cliënten van thuiszorgorganisatiesfrail elderlydementiaNL-OMON33422Proteion Thuis320